184 results
Thumbnail

D3.72 - Utility of Basophil Activation Testing in Drug and Peanut Allergy: Concordance with Clinical Outcomes

Thumbnail

D3.73 - Review of skin testing for delay hypersensitivity drug reactions, possible covariates involved in the results

Thumbnail

D3.77 - Hypersensitivity Reactions to Iodinated Contrast Media: A Single-Center Experience

Thumbnail

D3.84 - Delayed hypersensitivity to hydroxychloroquine with positive patch test

Thumbnail

D3.89 - Unexpected Culprit: The Role of Acrylates in Recurrent Anaphylaxis and Antibiotic Hypersensitivity

Thumbnail

D3.20 - Searching for an Alternative Contrast Agent in a Patient Allergic to Multiple Nonionic Iodinated Contrast Media

Thumbnail

D3.22 - Fixed Drug Eruption in a Patient with Vitiligo: localized patch testing as a diagnostic tool

Thumbnail

D3.252 - Azithromycin and Mycoplasma pneumonia: an unusual Stevens-Johnson syndrome case

Thumbnail

D3.256 - Is an Early-Type Hypersensitivity Reaction Possible with Both Peroral and Parenteral Anticoagulant Drugs? A Successful 2-Day Peroral Desensitization Protocol to Rivaroxaban

Thumbnail

D3.257 - Two cases of propofol anaphylaxis revealed by provocation test

Thumbnail

D3.258 - Probable drug- induced Enterocolitis Syndrome (DIES) caused by Amoxicillin

Thumbnail

D3.259 - KOLLIPHOR : An excipient to be futher explored

Thumbnail

D3.26 - Anaphylaxis associated with biosimilar Tocilizumab: in vitro and in vivo diagnosis

Thumbnail

D3.263 - Rare case of anaphylaxis to lidocaine in skin testing during perioperative anaphylaxis investigation

Thumbnail

D3.264 - Pioneering study evaluating the Basophil Activation Test (BAT), PENFAST and skin sensitization to penicillin in patients with gestational syphilis

Thumbnail

D3.265 - Biphasic anaphylaxis secondary to polyethylene glycol in a pediatric patient: a case report

Thumbnail

D3.269 - Drug-Induced Anaphylaxis in Children: A Comparative Analysis of Inpatient vs. Outpatient Settings

Thumbnail

D3.272 - Safety and Efficacy of Vancomycin and Other Antimicrobial Drug Desensitization in Pediatric Patients

Thumbnail

D3.273 - Assessing Anaphylaxis in COVID-19 vaccines: Application of amended Brighton Collaboration Criteria

Thumbnail

D3.274 - Succesful Omalizumab Desensitization in Two Children with Severe Allergic Asthma and Cronic Spontaneous Urticaria